IP Library › Assignment 045480/0960
Patent Assignment
Reel/Frame 045480/0960

Security Interest

Recorded: 2018-04-09 Pages: 17
Assignors
PROVECTUS BIOPHARMACEUTICALS, INC.
Executed: 2017-12-11
PROVECTUS PHARMATECH, INC.
Executed: 2017-12-11
PROVECTUS BIOTECH, INC.
Executed: 2017-12-11
PURE-IFIC, INC.
Executed: 2017-12-11
Assignee
SMITH, GREGORY LYNN
5730 SHAMROCK GLEN LANE, LEWISVILLE, NORTH CAROLINA, 27023
Covered Properties (21)
Method for Improved Imaging and Photodynamic Therapy
Patent: 6,493,570 →
Application: 09/184,388 →
Improved Methods for High Energy Phototherapeutics
Patent: 6,331,286 →
Application: 09/216,787 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,495,360 →
Application: 09/543,479 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,451,597 →
Application: 09/803,498 →
Publication: US 2001/0041354
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,541,223 →
Application: 09/803,609 →
Publication: US 2001/0044146
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,468,777 →
Application: 09/803,634 →
Publication: US 2001/0041361
Ultrasound Contrast Using Halogenated Xanthenes
Patent: 6,986,740 →
Application: 10/314,840 →
Publication: US 2003/0167006
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
Patent: 6,991,776 →
Application: 10/331,854 →
Publication: US 2003/0125376
Combination Antiperspirant and Antimicrobial Composition
Patent: 7,201,914 →
Application: 10/425,255 →
Publication: US 2003/0215408
Intracorporeal Medicaments for Photodynamic Treatment of Disease
Patent: 7,402,299 →
Application: 10/999,313 →
Publication: US 2005/0154049
Methods for Positron Emission Imaging with Radiolabeled Halogenated Xanthenes Diagnostic Agents
Patent: 7,338,652 →
Application: 11/050,512 →
Publication: US 2005/0276753
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
Patent: 8,470,296 →
Application: 11/715,780 →
Publication: US 2007/0208076
Topical Medicaments and Methods for Photodynamic Treatment of Disease
Patent: 8,974,363 →
Application: 11/936,963 →
Publication: US 2008/0118578
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes
Patent: 8,530,675 →
Application: 12/884,833 →
Publication: US 2011/0071217
Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Patent: 9,107,887 →
Application: 13/416,494 →
Publication: US 2012/0263677
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one(Rose Bengal) and Related Xanthenes
Patent: 9,422,260 →
Application: 13/916,408 →
Publication: US 2013/0274322
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes
Patent: 9,273,022 →
Application: 14/447,063 →
Publication: US 2014/0343296
Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Application: 14/748,579 →
Publication: US 2015/0290309
Combination of Rose Bengal and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Patent: 9,839,688 →
Application: 14/748,608 →
Publication: US 2015/0290165
Combination of Local and Systemic Immunomodulative Therapies for Melanoma and Liver Cancer
Patent: 9,808,524 →
Application: 14/748,634 →
Publication: US 2015/0290318
Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
Application: 14/974,357 →
Publication: US 2017/0173079
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 3, 2012
From: EAGLE, CRAIG J.
To: PFIZER, INC.
Reel/Frame 028485/0653 →
Assignment of Assignor's Interest Jul 3, 2012
From: DEES, H. CRAIG; WACHTER, ERIC A.; SINGER, JAMIE
To: PROVECTUS PHARMACEUTICALS, INC.
Reel/Frame 028485/0607 →
Assignment of Assignor's Interest Jan 19, 2016
From: SINGER, JAMIE; WACHTER, ERIC A.; LUTZ, MARLON; BABIAK, KEVIN
To: PROVECTUS PHARMACEUTICALS, INC.
Reel/Frame 037525/0138 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037648/0690 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037648/0389 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC
Reel/Frame 037648/0082 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037649/0217 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037649/0150 →
Security Interest Apr 4, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0389 →
Security Interest Apr 4, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0443 →
Security Interest Apr 4, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0498 →
Security Interest Apr 21, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0516 →
Security Interest Apr 21, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0594 →
Security Interest Apr 21, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0421 →
Security Interest Jun 26, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0878 →
Security Interest Jun 26, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SANDRA J.; TAUSK, SCOTT A.
Reel/Frame 042809/0817 →
Security Interest Jun 26, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0755 →
Security Interest Aug 1, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043156/0410 →
Security Interest Aug 1, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0439 →
Security Interest Aug 1, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0330 →
Security Interest Aug 9, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0210 →
Security Interest Aug 9, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0424 →
Security Interest Aug 9, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043245/0875 →
Security Interest Apr 9, 2018
From: PROVECTUS BIOPHARMACEUTICALS, INC.; PROVECTUS PHARMATECH, INC.; PROVECTUS BIOTECH, INC.; PURE-IFIC, INC.
To: FORTUNATO, PAUL M.; FORTUNATO, KATHLEEN E.
Reel/Frame 045478/0511 →
Security Interest Apr 9, 2018
From: PROVECTUS BIOPHARMACEUTICALS, INC.; PROVECTUS PHARMATECH, INC.; PROVECTUS BIOTECH, INC.; PURE-IFIC, INC.
To: HANSEN, CHRIS; HANSEN, STEPHANIE
Reel/Frame 045480/0437 →